Bicalutamide Description

Bicalutamide is an articulate non-steroidal anti-androgen for prostate cancer. It binds to the androgen receptor.

Bicalutamide is an antineoplastic hormonal abettor primarily used in the analysis of prostate cancer. Bicalutamide is a pure, nonsteroidal anti-androgen with affection for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors). Consequently, Bicalutamide blocks the activity of androgens of adrenal and testicular agent which activate the advance of accustomed and cancerous prostatic tissue. Prostate blight is mostly androgen-dependent and can be advised with surgical or actinic castration. To date, antiandrogen monotherapy has not consistently been crystalline to be agnate to castration.

Bicalutamide competes with androgen for the bounden of androgen receptors, appropriately blocking the activity of androgens of adrenal and testicular agent which activate the advance of accustomed and cancerous prostatic tissue.